In this study, the down-regulation of miR-192 and miR-462 may up-regulate the expression of MBNL1. MBNL1 can inhibit breast cancer metastasis, which is associated with reduced clinical metastatic relfront outcomes60. This evidence concerns the gene MBNL1 and breast carcinoma.